China Pharmaceutical Industry Report, 2003-2004
  • Nov/2004
  • Hard Copy
  • USD $950
  • Pages:50
  • Single User License
    (PDF Unprintable)       
  • USD $1,000
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,500
  • Hard Copy + Single User License
  • USD $1,150
      

Presenting the comparison of the pharmaceutical industry between the first three quarters of 2004 and 2003, the report aims to provide medical treatment information for medical apparatus companies, pharmaceutical companies and medical facilities, definitude the current situation of China’s pharmaceutical economy and the supply & demand intelligence.

1.Analysis of the total industry value of pharmaceutical 

2.Analysis of the main products' import and export quantity 
2.1 Comparison between import & export volume 
2.2 Comparison of import quantity
2.3 Comparison of export quantity 

3.Industry's general economic efficiency recovers
3.1 Total benefits of the industry
3.2 Benefits of the subsidiary industries
3.3 The investment growth tends to be steady

4.Different situations of the major subsidiary industries
4.1 Favorable prospects of the pharmaceutical raw material industry, but short-term adjustments will be hard to avoid
4.2 The duplication of production is very serious 
4.3 Chinese herbal drug medicine industry operates smoothly, with increasing technology contents
4.4 Biopharmaceutical industry is developing smoothly
4.5 Medical apparatus industry's economic efficiency recovers, and transnational corporations dominate the high-end market
Comparison of 2003 & 2004 pharmaceutical industry's added value
Comparison of 2003 & 2004 pharmaceutical industry's sales revenue
Comparison of 2003 & 2004 pharmaceutical industry's total volume of import and export trade
Comparison of 2003 & 2004 chemical apparatus industry's total import and export volume
Comparison of 2003 & 2004 pharmaceutical raw material gross export 
Comparison of 2003 & 2004 pharmaceutical industry's profits
Comparison of 2003 & 2004 herbal tablets' sale revenue

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统